Skip to main content
. 2013 Feb 13;34(13):3511–3522. doi: 10.1016/j.biomaterials.2013.01.075

Fig. 2.

Fig. 2

Extracellular anti-HCV activity and viral inactivation of Ctry2459. (A, B, C) HCV RNA and core protein content in infected Huh7.5.1 cells decreased both time- and dose-dependently after treatment with indicated concentrations of the Ctry2459 peptide. (D, E) ApoE, HCV E2, HCV core protein, HCV RNA content and viral infectivity were determined by the virucidal assay.